Henry Schein, Inc. (NASDAQ:HSIC) Shares Acquired by Thrivent Financial for Lutherans

Thrivent Financial for Lutherans boosted its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 10.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 116,843 shares of the company’s stock after acquiring an additional 11,428 shares during the period. Thrivent Financial for Lutherans owned 0.09% of Henry Schein worth $8,085,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. Versant Capital Management Inc grew its stake in Henry Schein by 274.6% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $32,000 after acquiring an additional 335 shares during the last quarter. Venturi Wealth Management LLC grew its stake in Henry Schein by 3,347.1% in the 4th quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock valued at $41,000 after acquiring an additional 569 shares during the last quarter. Quent Capital LLC grew its stake in Henry Schein by 91.2% in the 4th quarter. Quent Capital LLC now owns 677 shares of the company’s stock valued at $47,000 after acquiring an additional 323 shares during the last quarter. Smartleaf Asset Management LLC grew its stake in Henry Schein by 23.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock valued at $52,000 after acquiring an additional 143 shares during the last quarter. Finally, City State Bank acquired a new stake in Henry Schein in the 4th quarter valued at about $55,000. 96.62% of the stock is owned by institutional investors and hedge funds.

Henry Schein Trading Down 1.5 %

Shares of HSIC stock opened at $69.39 on Friday. The firm has a market cap of $8.62 billion, a P/E ratio of 28.56, a PEG ratio of 2.13 and a beta of 0.90. Henry Schein, Inc. has a 1-year low of $63.67 and a 1-year high of $82.49. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The firm’s 50-day simple moving average is $74.82 and its 200-day simple moving average is $72.61.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). The business had revenue of $3.19 billion for the quarter, compared to analyst estimates of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same period last year, the company posted $0.66 EPS. As a group, equities analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current year.

Insider Buying and Selling

In related news, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the sale, the chief executive officer now owns 62,688 shares of the company’s stock, valued at approximately $4,460,251.20. This represents a 6.05 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the sale, the director now directly owns 24,805 shares of the company’s stock, valued at approximately $1,762,147.20. This trade represents a 9.50 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company’s stock.

Analyst Ratings Changes

HSIC has been the topic of a number of research reports. Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and increased their price objective for the company from $69.00 to $84.00 in a research note on Monday, January 6th. Wells Fargo & Company initiated coverage on shares of Henry Schein in a report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 target price on the stock. Mizuho initiated coverage on shares of Henry Schein in a report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 target price on the stock. Jefferies Financial Group upped their target price on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a report on Thursday, January 23rd. Finally, UBS Group reduced their target price on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a report on Wednesday, February 26th. Six research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $81.10.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.